Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
FibroGen Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FGEN
Nasdaq
8731
https://www.fibrogen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for FibroGen Inc
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
- Apr 16th, 2024 3:33 pm
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
- Apr 16th, 2024 1:14 pm
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
- Apr 12th, 2024 2:23 pm
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
- Apr 12th, 2024 1:40 pm
Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
- Apr 8th, 2024 4:13 pm
Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
- Apr 6th, 2024 10:37 am
Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
- Apr 3rd, 2024 3:26 pm
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
- Apr 2nd, 2024 9:46 pm
Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
- Mar 28th, 2024 3:01 pm
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
- Mar 27th, 2024 12:50 pm
FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference
- Mar 26th, 2024 11:00 am
3 Nightmare Nasdaq Stocks Not Worth Holding Another Day
- Mar 20th, 2024 7:45 pm
Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals
- Mar 20th, 2024 3:46 pm
Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data
- Mar 20th, 2024 9:38 am
Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA
- Mar 19th, 2024 12:49 pm
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
- Mar 14th, 2024 12:23 pm
Acadia (ACAD) Down as Schizophrenia Study on Nuplazid Fails
- Mar 12th, 2024 3:06 pm
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
- Mar 11th, 2024 11:00 am
Novo Nordisk's (NVO) Wegovy Gets FDA Nod to Reduce Heart Risk
- Mar 11th, 2024 10:59 am
FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 1:09 pm
Scroll